Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 2.8/5
ABLBio (298380 KS)
Watchlist
11
Analysis
Health Care
•
South Korea
ABLBio, Inc. operates as a drugs development company. The Company develops and manufactures neurodegenerative diseases therapeutic drugs, oncology therapeutic drugs, and other products. ABLBio markets its products throughout Korea.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Quantitative Analysis
•
20 Jul 2025 23:05
KRX Foreign Holding Weekly (Jul 18th): Samsung Electronics, Sksquare, SK Hynix, Naver
We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, Sksquare, SK Hynix, Naver.
Ke Yan, CFA, FRM
Follow
115 Views
Share
bullish
•
ABLBio
•
07 Apr 2025 15:13
ABLBio (298380 KS): Continued License Out Deals and Milestone Payment Realization to Feed Pipeline
ABLBio partners with GSK to develop CNS treatments using Grabody-B, potentially receiving up to £2.075B in milestone payments and royalties....
Tina Banerjee
Follow
351 Views
Share
bullish
•
Thematic (Sector/Industry)
•
29 Jun 2025 00:30
APAC Healthcare Weekly (June 29)- RemeGen, Innovent, Daiichi, SanBio, Otsuka, Chugai, Glenmark
Last week couple of Chinese companies signed outlicensing deals with international players. Innovent got weight loss drug approval in China....
Tina Banerjee
Follow
474 Views
Share
bullish
•
Thematic (Sector/Industry)
•
04 May 2025 00:30
APAC Healthcare Weekly (May 4)- Takeda Pharma, Samsung Biologics, Celltrion, Dr. Reddy’s, Medanta
Takeda retained top slot in domestic market. Samsung Biologics signed major CDMO deal with US client. Celltrion got approval to start trial of...
Tina Banerjee
Follow
614 Views
Share
bullish
•
Quantitative Analysis
•
20 Apr 2025 23:05
KRX Foreign Holding Weekly (Apr 18th): Hdhms, Celltrion, SK Hynix, Samsung Electronics
We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Hdhms, Celltrion, SK Hynix, Samsung Electronics,...
Ke Yan, CFA, FRM
Follow
444 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.9
x